Cargando…
Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists
The roots and rhizomes of Valeriana jatamansi have long been used as folk medicine in Asia and usually named as “Zhizhuxiang” in Chinese for the treatment of abdominal distention and pain. However, its active ingredients and molecular targets for treatment of abdominal pain remain unrevealed. Inhibi...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099110/ https://www.ncbi.nlm.nih.gov/pubmed/30150936 http://dx.doi.org/10.3389/fphar.2018.00885 |
_version_ | 1783348596757757952 |
---|---|
author | Dong, Fa-Wu Jiang, He-Hai Yang, Liu Gong, Ye Zi, Cheng-Ting Yang, Dan Ye, Chen-Jun Li, Huan Yang, Jian Nian, Yin Zhou, Jun Hu, Jiang-Miao |
author_facet | Dong, Fa-Wu Jiang, He-Hai Yang, Liu Gong, Ye Zi, Cheng-Ting Yang, Dan Ye, Chen-Jun Li, Huan Yang, Jian Nian, Yin Zhou, Jun Hu, Jiang-Miao |
author_sort | Dong, Fa-Wu |
collection | PubMed |
description | The roots and rhizomes of Valeriana jatamansi have long been used as folk medicine in Asia and usually named as “Zhizhuxiang” in Chinese for the treatment of abdominal distention and pain. However, its active ingredients and molecular targets for treatment of abdominal pain remain unrevealed. Inhibitors of Ca(v)2.2 N-type voltage-gated calcium channels (VGCCs) are actively sought after for their potential in treating pain, especially chronic pain. As far as we know, the method used for seeking analgesic active ingredient from plant material has rarely been reported. The analgesic potentials of the EtOH extract (0.01 mg/ml) of the roots and rhizomes of V. jatamansi and its EtOAc, n-BuOH and H(2)O soluble parts (0.01 mg/ml, respectively) were tested herein on Ca(v)2.2, using whole-oocyte recordings in vitro by tow-electrode voltage clamp. The results indicated that the EtOAc-soluble part exhibited the most potent inhibition of Ca(v)2.2 peak current (20 mv). The EtOAc-soluble part was then subjected to silica gel column chromatography (CC) and giving 9 fractions. Phytochemical studies were carried out by repeated CC and extensive spectroscopic analyses after the fraction (0.01 mg/ml) was identified to be active and got seventeen compounds (1–17). All isolates were then sent for further bioactive verification (1 and 3 at concentration of 10 μM, others at 30 μM). In addition, the selectivity of the active compounds 1 and 3 were tested on various ion channels including Ca(v)1.2, Ca(v)2.1 and Ca(v)3.1 VGCCs and Kv1.2, Kv2.1, Kv3.1 and BK potassium channels. The results indicated that compound 1 and 3 (an abundant compound) inhibited Ca(v)2.2 with an EC(50) of 3.3 and 4.8 μM, respectively, and had weaker or no effect on Ca(v)1.2, Ca(v)2.1 and Ca(v)3.1 VGCCs and Kv1.2, Kv2.1, Kv3.1 and BK potassium channels. Compounds 1 and 3 appear to act as allosteric modulators rather than pore blockers of Ca(v)2.2, which may play crucial role in attenuating nociception. The results of present research indicated that the ethnopharmacological utilization of V. jatamansi for relieving the abdominal distention and pain may mediate through Ca(v)2.2 channel. Our work is the first demonstration of inhibition of Ca(v)2.2 by iridoids, which may provide a fresh source for finding new analgesics. |
format | Online Article Text |
id | pubmed-6099110 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-60991102018-08-27 Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists Dong, Fa-Wu Jiang, He-Hai Yang, Liu Gong, Ye Zi, Cheng-Ting Yang, Dan Ye, Chen-Jun Li, Huan Yang, Jian Nian, Yin Zhou, Jun Hu, Jiang-Miao Front Pharmacol Pharmacology The roots and rhizomes of Valeriana jatamansi have long been used as folk medicine in Asia and usually named as “Zhizhuxiang” in Chinese for the treatment of abdominal distention and pain. However, its active ingredients and molecular targets for treatment of abdominal pain remain unrevealed. Inhibitors of Ca(v)2.2 N-type voltage-gated calcium channels (VGCCs) are actively sought after for their potential in treating pain, especially chronic pain. As far as we know, the method used for seeking analgesic active ingredient from plant material has rarely been reported. The analgesic potentials of the EtOH extract (0.01 mg/ml) of the roots and rhizomes of V. jatamansi and its EtOAc, n-BuOH and H(2)O soluble parts (0.01 mg/ml, respectively) were tested herein on Ca(v)2.2, using whole-oocyte recordings in vitro by tow-electrode voltage clamp. The results indicated that the EtOAc-soluble part exhibited the most potent inhibition of Ca(v)2.2 peak current (20 mv). The EtOAc-soluble part was then subjected to silica gel column chromatography (CC) and giving 9 fractions. Phytochemical studies were carried out by repeated CC and extensive spectroscopic analyses after the fraction (0.01 mg/ml) was identified to be active and got seventeen compounds (1–17). All isolates were then sent for further bioactive verification (1 and 3 at concentration of 10 μM, others at 30 μM). In addition, the selectivity of the active compounds 1 and 3 were tested on various ion channels including Ca(v)1.2, Ca(v)2.1 and Ca(v)3.1 VGCCs and Kv1.2, Kv2.1, Kv3.1 and BK potassium channels. The results indicated that compound 1 and 3 (an abundant compound) inhibited Ca(v)2.2 with an EC(50) of 3.3 and 4.8 μM, respectively, and had weaker or no effect on Ca(v)1.2, Ca(v)2.1 and Ca(v)3.1 VGCCs and Kv1.2, Kv2.1, Kv3.1 and BK potassium channels. Compounds 1 and 3 appear to act as allosteric modulators rather than pore blockers of Ca(v)2.2, which may play crucial role in attenuating nociception. The results of present research indicated that the ethnopharmacological utilization of V. jatamansi for relieving the abdominal distention and pain may mediate through Ca(v)2.2 channel. Our work is the first demonstration of inhibition of Ca(v)2.2 by iridoids, which may provide a fresh source for finding new analgesics. Frontiers Media S.A. 2018-08-13 /pmc/articles/PMC6099110/ /pubmed/30150936 http://dx.doi.org/10.3389/fphar.2018.00885 Text en Copyright © 2018 Dong, Jiang, Yang, Gong, Zi, Yang, Ye, Li, Yang, Nian, Zhou and Hu. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology Dong, Fa-Wu Jiang, He-Hai Yang, Liu Gong, Ye Zi, Cheng-Ting Yang, Dan Ye, Chen-Jun Li, Huan Yang, Jian Nian, Yin Zhou, Jun Hu, Jiang-Miao Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title | Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title_full | Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title_fullStr | Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title_full_unstemmed | Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title_short | Valepotriates From the Roots and Rhizomes of Valeriana jatamansi Jones as Novel N-Type Calcium Channel Antagonists |
title_sort | valepotriates from the roots and rhizomes of valeriana jatamansi jones as novel n-type calcium channel antagonists |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099110/ https://www.ncbi.nlm.nih.gov/pubmed/30150936 http://dx.doi.org/10.3389/fphar.2018.00885 |
work_keys_str_mv | AT dongfawu valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT jianghehai valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT yangliu valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT gongye valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT zichengting valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT yangdan valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT yechenjun valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT lihuan valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT yangjian valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT nianyin valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT zhoujun valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists AT hujiangmiao valepotriatesfromtherootsandrhizomesofvalerianajatamansijonesasnovelntypecalciumchannelantagonists |